Quarterly report · Q3
2796.TEDINET S100T8YK
Period2023-06-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥40.7bn | 2023-06-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥863m | 2023-06-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥896m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥799m | 2023-06-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥890m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥761m | 2023-06-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥722m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥177m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥333m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥208m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥187m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥218m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥26.4bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥23.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥22.9bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.5bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.2bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥17.22 | 2023-06-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.42 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.45 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.24 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.45 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥16.48 | 2023-06-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.89 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥16.89 | 2022-06-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 29.0% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.4% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2024-02-29 | ¥593m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2024-02-29 | ¥593m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2024-02-29 | ¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2024-02-29 | −¥250m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥6.2bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥6.2bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥45m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥456m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥456m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥33m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥33.1bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥33.1bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥83m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥40.1bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥40.1bn |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2024-02-29 | ¥40.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2024-02-29 | ¥40.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2023-02-28 | ¥37m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥226m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥170m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥56m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥70m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 396
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 尻 慶 太 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)篠 田 友 彦 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 38730000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 40674000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 52030000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 890000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 799000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1431000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 208000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 177000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 333000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 217000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 187000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 372000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6833000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 7954000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6987000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 22935000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 26425000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 23421000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 22.24 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 17.22 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 35.45 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 16.89 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 16.48 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 26.89 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.284 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.290 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.285 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 14.45 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -8.42 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 12060381 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 12060381 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 12060381 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 12060381 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 321100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 117333 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 11733300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5981 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 12060381 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 117333 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 321100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |